Article

Use of Stem Cell-Derived Cardiomyocyte and Nasal Epithelium Models to Establish a Multi-Tissue Model Platform to Validate Repurposed Drugs Against SARS-CoV-2 Infection

2024-05-23

Abstract excerpt

The novel coronavirus disease (COVID-19) and any future coronavirus outbreaks will require more affordable, effective and safe treatment options to complement current ones such as Paxlovid . Drug repurposing can be a promising approach if we are able to find a rapid, robust and reliable way to down-select and screen candidates using in silico and in vitro approaches. With repurposed drugs, ex vivo models could...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 47347767-35f9-52e7-be15-295483cacb27
DOI: 10.1101/2024.05.22.595397

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Use of Stem Cell-Derived Cardiomyocyte and Nasal Epithelium Models to Establish a Multi-Tissue Model Platform to Validate Repurposed Drugs Against SARS-CoV-2 InfectionDOI 10.1101/2024.05.22.595397Read

A human primary airway microphysiological system infected with SARS-CoV-2 distinguishes the treatment efficacy between nirmatrelvir and repurposed compounds fluvoxamine and amodiaquineSemantic proximity Read

Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung OrganoidsSemantic proximity Read

Development of robust antiviral assays using relevant apical-out human airway organoidsSemantic proximity Read

Use of Human Lung Tissue Models for Screening of Drugs Against SARS-CoV-2 InfectionSemantic proximity Read

Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium <i>in vitro</i>Semantic proximity Read

Recent Advances of COVID-19 Modeling Based on Regenerative MedicineSemantic proximity Read

Preclinical and Clinical Study of Efficacy of NAOQ19 against SARS-COV2: A Comprehensive EvaluationSemantic proximity Read

Anti-Fibrotic Agents Could Be the Game Changer for Post‑COVID Pulmonary Fibrosis Treatment – A Mini ReviewSemantic proximity Read

Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2Semantic proximity Read

Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infectionSemantic proximity Read

Assessing the cardiac safety of β-d-N4-hydroxycytidine (NHC) and Molnupiravir on hiPSC-Derived Cardiomyocyte Platform at Physiologically Relevant ConcentrationsSemantic proximity Read

Viral pandemic preparedness: A pluripotent stem cell-based machine-learning platform for simulating SARS-CoV-2 infection to enable drug discovery and repurposing.Semantic proximity Read